The Flapless Approach in Periodontal Regeneration
Launched by UNIVERSITY OF TURIN, ITALY · Jul 8, 2022
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of periodontitis stage III or IV;
- • presence of at least one tooth with ≥6 mm associated with a radiographic intrabony defect ≥3 mm at least 2 months after the completion of non-surgical therapy;
- • a full-mouth plaque score and full-mouth bleeding score \<15% at the time of the experimental procedure;
- • signed informed consent.
- Exclusion Criteria:
- • relevant medical disorders contraindicating periodontal surgery or detrimental to periodontal healing;
- • consumption of drugs known to affect periodontal status;
- • pregnancy and lactation;
- • third molars, teeth with furcation involvement or inadequate endodontic treatment and/or prosthetic restoration;
- • heavy smokers \>10 cigarettes per day.
About University Of Turin, Italy
The University of Turin, located in Italy, is a prestigious academic institution renowned for its commitment to research and innovation in the medical field. As a clinical trial sponsor, the university leverages its extensive expertise and resources to advance scientific knowledge and improve patient outcomes. Collaborating with a network of healthcare professionals and researchers, the University of Turin conducts rigorous clinical trials that adhere to the highest ethical and regulatory standards. Its focus on translational research ensures that findings contribute to the development of effective therapies and healthcare solutions, enhancing the overall well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Turin, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials